By Susan Cornwell WASHINGTON (Reuters) – If the U.S. Supreme Court blows up the tax subsidies at the heart of Obamacare in June, Republicans hope to deliver on their promise to offer an alternative healthcare plan. Two front-running Republican options at an early stage in Congress include a refundable tax credit that experts say is virtually the same thing as the Obamacare tax subsidy being challenged before the Supreme Court.
Iran is charging Washington Post journalist Jason Rezaian with four crimes, including espionage, the newspaper said on Monday in a report offering the first details about the exact charges against him. Rezaian, the Post’s bureau chief in Tehran, was detained last year in Iran. Among the charges, he is accused of “collaborating with hostile governments” and “propaganda against the establishment,” according to a statement from Rezaian’s attorney, Leilah Ahsan, the
European leaders urge action after what could be the Mediterranean’s worst migrant tragedy.
The attack widens the circle of nations affected by the group’s atrocities.
Remembering the Oklahoma City bombing 20 years later
New York Gov. Andrew Cuomo is heading to Havana, the first American governor to visit Cuba since the recent thaw in relations with the communist nation. Whether his trade mission generates anything more …
By Magdalena Mis LONDON (Thomson Reuters Foundation) – Poor quality drugs, not fake medicines, are the real threat in fight against malaria, causing deaths and increasing the risk of drug resistance, researchers said on Monday. While previous reports have suggested that up to a third of malaria drugs could be fake, researchers at the London School of Hygiene and Tropical Medicine who analyzed anti-malaria drugs in Cambodia and Tanzania, found
Teva Pharmaceutical Industries Ltd has agreed to pay $512 million to settle a class action claiming that Cephalon Inc, which Teva bought in 2011, used anticompetitive settlements to delay generic versions of its wakefulness drug Provigil, according to court papers. The settlement is the largest ever to be paid to drug buyers that bought directly from manufacturers over allegations of delaying generic drugs, according to a motion to approve the
By Lisa Rapaport (Reuters Health) – Opiate prescriptions and overdoses in the U.S. have declined since the debut of an abuse-resistant version of the painkiller OxyContin and the market withdrawal of the narcotic Darvon, a study finds. Researchers reviewed insurance claims records with data on prescriptions and hospitalizations for more than 30 million adults covered by UnitedHealthCare from 2003 to 2012. In the two years after OxyContin was reformulated and
by guest blogger Pam Peeke, MD, MPH, FACP, best-selling author and expert on health, fitness, and nutritionLet’s say you’re at a point in your wellness journey where you are gradually and proudly hitting critical milestones: You can briskly walk two miles without speed-dialing 911; you can zip up pants and jackets all the way (it’s no longer…